Location History:
- Vienna, AT (2018 - 2020)
- Bisamberg, AT (2022 - 2023)
Company Filing History:
3 out of 13 
1 out of 49 
1 out of 1 
Years Active: 2018-2023
Title: **The Innovative Journey of Matthias Hackl**
Introduction
Matthias Hackl, a dedicated inventor based in Bisamberg, Austria, has made notable contributions to the field of biomedical research through his innovative work. With a total of two patents to his name, he has focused on developing methods for diagnosing and predicting cellular health.
Latest Patents
One of Matthias Hackl's latest patents is centered on **biomarkers for detecting senescent cells**. This invention proposes a method for identifying senescent cells by quantifying the levels of selected microRNAs (miRNAs) in samples obtained from subjects. This breakthrough could have significant implications in understanding aging and cellular health.
Another remarkable invention relates to **micro-RNA signatures for predicting liver dysfunction**. This patent details an in vitro method that assesses the risk of liver dysfunction in patients post-partial liver resection. The method involves analyzing the expression levels of specific miRNAs, including miR-151a, miR-192, and miR-122, and comparing these levels to reference values to classify patients into high-risk or low-risk categories.
Career Highlights
Throughout his career, Matthias Hackl has been associated with renowned institutions such as Tamirna GmbH and the Medical University of Vienna. His work in these companies has contributed to advancing medical research and exploring innovative solutions in biotechnology.
Collaborations
Matthias has collaborated with several esteemed professionals, including Alice Assinger and Patrick Starlinger. These partnerships have played a crucial role in enhancing his research and furthering the impact of his inventions in the scientific community.
Conclusion
Matthias Hackl stands out as a prominent inventor whose innovative patents have the potential to significantly impact the fields of cellular biology and liver health. With his dedication to research and collaboration, he continues to pave the way for advancements in medical science that can improve patient outcomes and enhance our understanding of cellular mechanisms.